As SMAD3 and other TGF-β1 signaling genes have been linked to the pathobiology of IBD through genome-wide association studies and other genomic screenings (81–84), understanding molecular mechanisms whereby TSP1 activates TGF-β1 will likely provide a greater understanding of IBD pathogenesis. This evidence concerns the gene THBS1 and inflammatory bowel disease.